Success Metrics

Clinical Success Rate
84.2%

Based on 32 completed trials

Completion Rate
84%(32/38)
Active Trials
7(11%)
Results Posted
44%(14 trials)
Terminated
6(9%)

Phase Distribution

Ph phase_4
17
27%
Ph phase_1
9
14%
Ph phase_2
16
25%
Ph phase_3
11
17%
Ph early_phase_1
2
3%
Ph not_applicable
9
14%

Phase Distribution

11

Early Stage

16

Mid Stage

28

Late Stage

Phase Distribution64 total trials
Early Phase 1First-in-human
2(3.1%)
Phase 1Safety & dosage
9(14.1%)
Phase 2Efficacy & side effects
16(25.0%)
Phase 3Large-scale testing
11(17.2%)
Phase 4Post-market surveillance
17(26.6%)
N/ANon-phased studies
9(14.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

32 of 40 finished

Non-Completion Rate

20.0%

8 ended early

Currently Active

7

trials recruiting

Total Trials

64

all time

Status Distribution
Active(11)
Completed(32)
Terminated(8)
Other(13)

Detailed Status

Completed32
unknown13
Recruiting6
Terminated6
Not yet recruiting4
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
64
Active
7
Success Rate
84.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (3.1%)
Phase 19 (14.1%)
Phase 216 (25.0%)
Phase 311 (17.2%)
Phase 417 (26.6%)
N/A9 (14.1%)

Trials by Status

active_not_recruiting12%
recruiting69%
completed3250%
unknown1320%
withdrawn23%
not_yet_recruiting46%
terminated69%

Recent Activity

Clinical Trials (64)

Showing 20 of 64 trialsScroll for more
NCT07318155Phase 2

A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease

Recruiting
NCT07077746Phase 2

HB-adMSCs for the Treatment of Crohn's Disease

Recruiting
NCT07490808Not Applicable

Peri-procedural Hydration to Prevent Acute Kidney Injury After Pulsed Field Ablation for Atrial Fibrillation

Recruiting
NCT06303570Phase 2

A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in Participants With Dercum's Disease Lipomas

Active Not Recruiting
NCT07526974Phase 3

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )

Not Yet Recruiting
NCT07437339Phase 4

Volume Reduction for Open Fracture Irrigation

Recruiting
NCT07519109Phase 1

Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.

Not Yet Recruiting
NCT07140939Phase 3

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat

Not Yet Recruiting
NCT07353307Phase 3

A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia After Abdominal Surgery in China.

Recruiting
NCT07240987Phase 1

Mesenchymal Stem Cells for Chronic Kidney Diseases

Not Yet Recruiting
NCT05752279Phase 3

Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis

Recruiting
NCT06823180Phase 4

Hydromorphone Hydrochloride Epidural Preemptive Analgesia for Postoperative Pain After Cesarean Section

Completed
NCT03772990Phase 4

Calcium Administration in Cardiac Surgery

Completed
NCT03113760Phase 3

Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency

Completed
NCT05811676Phase 3

Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women With Placenta Previa

Completed
NCT06087601Phase 4

The Impact of Genicular Nerves Chemical Neurolysis on the Quality of Life of Patients with Advanced Knee Osteoarthritis.

Completed
NCT06304324Phase 4

Dexmedetomidine Vs Dexamethasone in Popliteal Nerve Block

Unknown
NCT06086431Phase 4

Dexamethasone Vs. Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery

Completed
NCT06086418Phase 4

Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Pediatric Ankle Surgery

Completed
NCT04410042Phase 3

Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
64